Shouval D
Liver Unit, Hadassah University Hospital, Jerusalem, Israel.
Haemophilia. 1998 Jul;4(4):587-94. doi: 10.1046/j.1365-2516.1998.440587.x.
At the end of the 20th century active immunization against hepatitis A and B has been introduced into routine medical practice. Therefore, patients at risk, and especially those with coagulation disorders, should be immunized at the earliest age possible. In contrast, development of an efficacious vaccine against hepatitis C remains an important goal for the next decade.
20世纪末,甲型和乙型肝炎的主动免疫已被引入常规医疗实践。因此,高危患者,尤其是有凝血障碍的患者,应尽早接种疫苗。相比之下,开发一种有效的丙型肝炎疫苗仍是未来十年的一个重要目标。